Treatment and prevention of brain damage
1402_ 7/2/13 - Here's another win with CU TTO. Dr. Kim Heidenreich, Professor of Pharmacology and Neuroscience at the University of Colorado-School of Medicine, in collaboration with Dr. Greg Miknis and the team at the Colorado Center for Drug Discovery (C2D2) at CSU, have made great strides in developing novel therapies for the treatment and prevention of brain damage caused by traumatic brain injury (TBI). In 2007, Kim’s lab discovered that a very potent inflammatory mediator, normally not found in the central nervous system, is present in the brain after TBI. Kim discovered that if this inflammatory mediator is blocked, secondary injury to the brain and the deleterious effects of TBI can be prevented. Together, Kim and Greg have developed a novel series of compounds that can inhibit this inflammatory molecule. The project is now moving toward advanced pre clinical studies that if successful will bring the program one step closer to a clinically approved drug, benefiting victims of this growing unmet medical need. When Larry interviewed Kim and Greg which was arranged by Matt Pink, Licensing Manager for the Colorado University Tech Transfer Office many interesting and valuable points were discussed. You will learn about the incidence of TBI and concussion as well as appreciate why TBI is a major public health problem. This interview will hopefully provide HOPE for listeners who have experienced a TBI or health providers for TBI patients. There is increased nonfederal funding for TBI (GE and NFL gifts) that is focused on diagnosis of TBI via blood bio markers or neural imaging. This is great but we also need more funding for developing TBI treatments ...Listen for more...
RELATED LINKS: CU Technology Transfer Office || Traumatic Brain Injury || CU TTO Channel || TTO Blog || Colorado Center for Drug Discovery (C2D2) || Mastering Change || KEYWORDS:Kim Heidenreich, Greg Miknis, Neuroscience, University of Colorado-School of Medicine, Colorado Center for Drug Discovery, C2D2, CSU, Traumatic Brain Injury, Inflammatory Mediator, CUTTO, > bytes=6579412
LISTEN TO: Kim Heidenreich, PhD and Greg Miknis, PhD
Powered by Podbean.com